TIDMOEX
RNS Number : 7234E
Oilex Ltd
10 May 2017
ASX Announcement
10 May 2017
ASX: OEX
AIM: OEX
Tranche 2 Shares Issued and Section 708A(5)(e) Notice
Oilex Ltd (the Company) is pleased to advise that it has today
issued the Tranche 2 shares following shareholder approval on 3 May
2017. The issue of the Tranche 2 securities is pursuant to the
GBP1.1 million gross capital raising announced on 16 March 2017
(Placement). The Placement, to investors in the EU, is to support
the Company's planned 2017 work programme and working capital
requirements.
Oilex gives notice under section 708A(5)(e) of the Corporations
Act 2001 (Cth) (Act) that:
1. Oilex issued the Shares without disclosure to investors under
Part 6D.2 of the Act;
2. as at the date of this notice, Oilex has complied with:
(a) the provisions of Chapter 2M of the Act as they apply to Oilex; and
(b) section 674 of the Act; and
3. as at the date of this notice, there is no information that
is 'excluded information' within the meaning of sections 708A(7)
and 708A(8) of the Act.
The Company advises that an application has also been made for
the admission to trading on AIM and it anticipates the shares to be
admitted to trading on AIM on 11 May 2017.
Attached is the related Appendix 3B.
For and on behalf of Oilex Ltd
Mark Bolton
Chief Financial Officer & Company Secretary
For further information, please contact:
Investor AIM Broker AIM Nominated Media Enquires Media Enquiries
Enquiries Cornhill Adviser (UK) (Aus)
Oilex Capital Strand Hanson Vigo Communications Citadel-MAGNUS
Ltd Limited Limited Public Relations Michael
Joe Salomon Broker Nominated Patrick Weir
Managing Colin Rowbury Adviser d'Ancona/Chris Email:
Director Email: Rory Murphy/Ritchie McMahon mweir@citadelmagnus.c
Email: colinr@cornhillcapital. Balmer Email: om
oilex@oilex.com.au com Email: patrick.dancona@vigoc Tel: +618
Tel: +61 Tel: +44 oilex@strandhanson.co omms.com 6160 4900
8 9485 20 3700 .uk chris.mcmahon@vigocom Australia
3200 2516 Tel: +44 ms.com
Australia UK 20 7409 Tel: +44 20
3494 7830 9700
UK
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement,
application for quotation of additional securities
and agreement
Information or documents not available now must be given to ASX
as soon as available. Information and documents given to ASX become
ASX's property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98,
01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05,
01/08/12, 04/03/13
Name of entity
OILEX LTD
--------------
ABN
50 078 652 632
---------------
We (the entity) give ASX the following information.
Part 1 -- All issues
You must complete the relevant sections (attach sheets if there
is not enough space).
1 +Class of +securities Fully Paid Ordinary
issued or to be issued Shares
2 Number of +securities 190,353,385 fully paid
issued or to be issued ordinary shares
(if known) or maximum
number which may be
issued
3 Principal terms of Fully Paid Ordinary
the +securities (eg, Shares
if options, exercise
price and expiry date;
if partly paid +securities,
the amount outstanding
and due dates for payment;
if +convertible securities,
the conversion price
and dates for conversion)
------------------------
4 Do the (+) securities Yes.
rank equally in all New ordinary shares will
respects from the rank equally with existing
date of allotment ordinary shares.
with an existing
+class of quoted
+securities?
If the additional
securities do not
rank equally, please
state:
* the date from which they do
* the extent to which they participate for the next
dividend, (in the case of a trust, distribution) or
interest payment
* the extent to which they do not rank equally, other
than in relation to the next dividend, distribution
or interest payment
------------------------------
5 Issue price or consideration Ordinary shares GBP0.00225
($0.004) per share
------------------------------
6 Purpose of the issue The net proceeds will
(If issued as consideration be applied towards the
for the acquisition analysis of the Cambay-23z
of assets, clearly core sample, subsurface
identify those assets) studies and associated
Cambay field operations
in India, as well as working
capital.
------------------------------
6a Is the entity an
(+) eligible entity Yes
that has obtained
security holder approval
under rule 7.1A?
If Yes, complete
sections 6b - 6h
in relation to the
+securities the subject
of this Appendix
3B, and comply with
section 6i
------------------------------
6b The date the security
holder resolution 23 November 2016
under rule 7.1A was
passed
------------------------------
6c Number of (+) securities
issued without security Not applicable
holder approval under
rule 7.1
------------------------------
6d Number of (+) securities
issued with security Not applicable
holder approval under
rule 7.1A
------------------------------
6e Number of +securities Not applicable
issued with security
holder approval under
rule 7.3, or another
specific security
holder approval (specify
date of meeting)
------------------------------
6f Number of (+) securities Not applicable
issued under an exception
in rule 7.2
------------------------------
6g If (+) securities
issued under rule
7.1A was issue price
at least 75% of 15
day VWAP as calculated
under rule 7.1A.3?
Include the (+) issue
date and both values.
Include the source
of the VWAP calculation.
------------------------------
6h If (+) securities were Not applicable
issued under rule 7.1A
for non-cash consideration,
state date on which
valuation of consideration
was released to ASX
Market Announcements
--------------------------------------
6i Calculate the entity's Listing Rule 7.1: 216,029,322
remaining issue capacity Listing Rule 7.1A: 35,527,366
under rule 7.1 and rule
7.1A - complete Annexure
1 and release to ASX
Market Announcements
-------------------------------------------------------------
7 (+) Issue dates 10 May 2017
Notes: The issue date
may be prescribed by
ASX (refer to the definition
of issue date in rule
19.12). For example,
the issue date for a
pro rata entitlement
issue must comply with
the applicable timetable
in appendix 7A.
Cross reference: item
33 of Appendix 3B.
-------------------------------------------------------------
8 Number and +class of Number (+) Class
all +securities quoted
on ASX (including the
(+) securities in section
2 if applicable)
-------------------------------- ---------------------------
1,684,120,899 Fully Paid Ordinary
Shares
-------------------------------- ---------------------------
9 Number and +class of Number +Class
all +securities not
quoted on ASX (including
the securities in section
2 if applicable)
-------------------------------- ---------------------------
275,000 $0.25 Options
due 05/08/2017
2,000,000 $0.25 Options
due 11/11/2017
5,000,000 $0.10 Options
due 22/12/2017
275,000 $0.35 Options
due 05/08/2018
-------------------------------- ---------------------------
10 Dividend policy (in
the case of a trust, The Company's dividend
distribution policy) policy will apply to
on the increased capital the new shares in the
(interests) same way it applies to
existing shares in the
Company.
-------------------------------------------------------------
Part 2 -- Pro rata issue
11 Is security holder Not applicable
approval required?
---------------
12 Is the issue renounceable
or non-renounceable?
---------------
13 Ratio in which
the +securities
will be offered
14 +Class of +securities
to which the offer
relates
---------------
15 +Record date to
determine entitlements
---------------
16 Will holdings on
different registers
(or subregisters)
be aggregated for
calculating entitlements?
---------------
17 Policy for deciding
entitlements in
relation to fractions
---------------
18 Names of countries
in which the entity
has security holders
who will not be
sent new issue
documents
Note: Security
holders must be
told how their
entitlements are
to be dealt with.
Cross reference:
rule 7.7.
---------------
19 Closing date for
receipt of acceptances
or renunciations
---------------
20 Names of any underwriters
---------------
21 Amount of any underwriting
fee or commission
---------------
22 Names of any brokers
to the issue
---------------
23 Fee or commission
payable to the
broker to the issue
---------------
24 Amount of any handling
fee payable to brokers
who lodge acceptances
or renunciations
on behalf of security
holders
25 If the issue is contingent
on security holders'
approval, the date
of the meeting
26 Date entitlement
and acceptance form
and offer documents
will be sent to persons
entitled
27 If the entity has
issued options, and
the terms entitle
option holders to
participate on exercise,
the date on which
notices will be sent
to option holders
28 Date rights trading
will begin (if applicable)
29 Date rights trading
will end (if applicable)
30 How do security holders
sell their entitlements
in full through a
broker?
31 How do security holders
sell part of their
entitlements through
a broker and accept
for the balance?
32 How do security holders
dispose of their
entitlements (except
by sale through a
broker)?
33 +Issue date
Part 3 -- Quotation of securities
You need only complete this section if you are applying for
quotation of securities
34 Type of securities
(tick one)
(a) ü (+) Securities described in Part 1
(b) o All other (+) securities
Example: restricted securities at the
end of the escrowed period, partly paid
securities that become fully paid, employee
incentive share securities when restriction
ends, securities issued on expiry or
conversion of convertible securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing the information or documents
35 If the +securities are +equity securities,
the names of the 20 largest holders of
the additional +securities, and the number
and percentage of additional +securities
held by those holders
36 If the +securities are +equity securities,
a distribution schedule of the additional
+securities setting out the number of
holders in the categories
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over
37 A copy of any trust deed for the additional
+securities
Entities that have ticked box 34(b)
-----------------
38 Number of securities for which +quotation is Not applicable
sought
-------------------
39 +Class of +securities for which quotation is
sought
-------------------
40 Do the +securities rank equally in all respects
from the +issue date with an existing +class
of quoted +securities?
If the additional +securities do not rank equally,
please state:
* the date from which they do
* the extent to which they participate for the next
dividend, (in the case of a trust, distribution) or
interest payment
* the extent to which they do not rank equally, other
than in relation to the next dividend, distribution
or interest payment
-------------------
41 Reason for request for quotation now
Example: In the case of restricted securities,
end of restriction period
(if issued upon conversion of another (+) security,
clearly identify that other (+) security)
-------------------
42 Number and +class of Number (+) Class
all +securities quoted
on ASX (including the
securities in clause
38)
------- ----------
Quotation agreement
1 +Quotation of our additional +securities is in ASX's absolute
discretion. ASX may quote the +securities on any conditions it
decides.
2 We warrant the following to ASX.
-- The issue of the +securities to be quoted complies with the
law and is not for an illegal purpose.
-- There is no reason why those +securities should not be granted +quotation.
-- An offer of the +securities for sale within 12 months after
their issue will not require disclosure under section 707(3) or
section 1012C(6) of the Corporations Act.
Note: An entity may need to obtain appropriate warranties from
subscribers for the securities in order to be able to give this
warranty
-- Section 724 or section 1016E of the Corporations Act does not
apply to any applications received by us in relation to any
+securities to be quoted and that no-one has any right to return
any +securities to be quoted under sections 737, 738 or 1016F of
the Corporations Act at the time that we request that the
+securities be quoted.
-- If we are a trust, we warrant that no person has the right to
return the +securities to be quoted under section 1019B of the
Corporations Act at the time that we request that the +securities
be quoted.
3 We will indemnify ASX to the fullest extent permitted by law
in respect of any claim, action or expense arising from or
connected with any breach of the warranties in this agreement.
4 We give ASX the information and documents required by this
form. If any information or document not available now, will give
it to ASX before +quotation of the +securities begins. We
acknowledge that ASX is relying on the information and documents.
We warrant that they are (will be) true and complete.
Mark Bolton
Company Secretary
Appendix 3B - Annexure 1
Calculation of placement capacity under rule 7.1 and rule 7.1A
for (+) eligible entities
Introduced 01/08/12, Amended 04/03/13
Part 1
Rule 7.1 - Issues exceeding 15% of capital
-------------------------------------------------------------------------------------------------
Step 1: Calculate "A", the base figure from
which the placement capacity is calculated
-------------------------------------------------------------------------------------------------
Insert number of fully
paid (+) ordinary securities
on issue 12 months
before the (+) issue
date or date of agreement
to issue 1,180,426,999
-------------------------------------------------------------- ---------------------------------
Add the following:
* Number of fully paid (+) ordinary securities issued 12,987,013 (issued 23/11/2016)
in that 12 month period under an exception in rule 2,000,000 (issued 17/03/2017)
7.2
-------------------------------------------------------------- ---------------------------------
Approval as at 3 May 2017
* Number of fully paid (+) ordinary securities issued General Meeting
in that 12 month period with shareholder approval 162,738,273 (issued 24/03/2017)
190,535,385 (issued 10/05/2017)
-------------------------------------------------------------- ---------------------------------
* Number of partly paid (+) ordinary securities that
became fully paid in that 12 month period
-------------------------------------------------------------- ---------------------------------
Note:
* Include only ordinary securities here - other classes
of equity securities cannot be added
* Include here (if applicable) the securities the
subject of the Appendix 3B to which this form is
annexed
* It may be useful to set out issues of securities on
different dates as separate line items
-------------------------------------------------------------- ---------------------------------
Subtract the number Nil
of fully paid (+) ordinary
securities cancelled
during that 12 month
period
-------------------------------------------------------------- ---------------------------------
"A" 1,548,687,670
-------------------------------------------------------------- ---------------------------------
Step 2: Calculate 15% of "A"
------------------------------------------------------------------------------------------------
"B" 0.15
[Note: this value cannot
be changed]
------------------------------------------------------------- ---------------------------------
Multiply "A" by 0.15 232,303,150
------------------------------------------------------------- ---------------------------------
Step 3: Calculate "C", the amount of placement
capacity under rule 7.1 that has already been
used
------------------------------------------------------------------------------------------------
Insert number of
(+) equity securities 16,273,828 (issued 31/03/2017)
issued or agreed
to be issued in that
12 month period not
counting those issued:
* Under an exception in rule 7.2
* Under rule 7.1A
* With security holder approval under rule 7.1 or rule
7.4
Note:
* This applies to equity securities, unless
specifically excluded - not just ordinary securities
* Include here (if applicable ) the securities the
subject of the Appendix 3B to which this form is
annexed
* It may be useful to set out issues of securities on
different dates as separate line items
------------------------------------------------------------- ---------------------------------
"C" 16,273,828
------------------------------------------------------------- ---------------------------------
Step 4: Subtract "C" from ["A" x "B"] to calculate
remaining placement capacity under rule 7.1
------------------------------------------------------------------------------------------------
"A" x 0.15
Note: number must
be same as shown
in Step 2 232,303,150
------------------------------------------------------------- ---------------------------------
Subtract "C"
Note: number must
be same as shown
in Step 3 16,273,828
------------------------------------------------------------- ---------------------------------
Total ["A" x 0.15] 216,029,322
- "C" [Note: this is the remaining
placement capacity under
rule 7.1]
------------------------------------------------------------- ---------------------------------
Part 2
Rule 7.1A - Additional placement capacity for
eligible entities
--------------------------------------------------------------------------------------------------
Step 1: Calculate "A", the base figure from
which the placement capacity is calculated
--------------------------------------------------------------------------------------------------
"A"
Note: number must be
same as shown in Step
1 of Part 1 1,548,687,670
-------------------------------------------------------------- ----------------------------------
Step 2: Calculate 10% of "A"
--------------------------------------------------------------------------------------------------
"D" 0.10
Note: this value cannot
be changed
-------------------------------------------------------------- ----------------------------------
Multiply "A" by 0.10 154,868,767
-------------------------------------------------------------- ----------------------------------
Step 3: Calculate "E", the amount of placement
capacity under rule 7.1A that has already been
used
--------------------------------------------------------------------------------------------------
Insert number of equity
securities issued or 108,492,183 (issued 24/03/2017)
agreed to be issued 10,849,218 (issued 31/03/2017)
in that 12 month period
under rule 7.1A
Notes:
* This applies to equity securities - not just ordinary
securities
* Include here - if applicable - the securities the
subject of the Appendix 3B to which this form is
annexed
* Do not include equity securities issued under rule
7.1 (they must be dealt with in Part 1), or for which
specific security holder approval has been obtained
* It may be useful to set out issues of securities on
different dates as separate line items
-------------------------------------------------------------- ----------------------------------
"E" 119,341,401
-------------------------------------------------------------- ----------------------------------
Step 4: Subtract "E" from ["A" x "D"] to calculate
remaining placement capacity under rule 7.1A
--------------------------------------------------------------------------------------------------
"A" x 0.10
Note: number must be
same as shown in Step
2 154,868,767
-------------------------------------------------------------- ----------------------------------
Subtract "E"
Note: number must be
same as shown in Step
3 119,341,401
-------------------------------------------------------------- ----------------------------------
Total ["A" x 0.10] 35,527,366
- "E" Note: this is the remaining
placement capacity under
rule 7.1A
-------------------------------------------------------------- ----------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCKMGMKRGVGNZG
(END) Dow Jones Newswires
May 10, 2017 04:57 ET (08:57 GMT)
Synergia Energy (LSE:SYN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Synergia Energy (LSE:SYN)
Historical Stock Chart
From Apr 2023 to Apr 2024
